{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:28:27Z","timestamp":1787239707920,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Albireo Pharma, Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Progressive familial intrahepatic cholestasis is a rare, heterogeneous group of liver disorders of autosomal recessive inheritance, characterised by an early onset of cholestasis with pruritus and malabsorption, which rapidly progresses, eventually culminating in liver failure. For children and their parents, PFIC is an extremely distressing disease. Significant pruritus can lead to severe cutaneous mutilation and may affect many activities of daily living through loss of sleep, irritability, poor attention, and impaired school performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Databases including MEDLINE and Embase were searched for publications on PFIC prevalence, incidence or natural history, and the economic burden or health-related quality of life of patients with PFIC. Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three systematic reviews and twenty-two studies were eligible for inclusion for the epidemiology of PFIC including a total of 2603 patients. Study periods ranged from 3 to 33\u00a0years. Local population prevalence of PFIC was reported in three studies, ranging from 9.0 to 12.0% of children admitted with cholestasis, acute liver failure, or splenomegaly. The most detailed data come from the NAPPED study where native liver survival of &gt;15 years is predicted in PFIC2 patients with a serum bile\u00a0 acid concentration below 102\u00a0\u00b5mol\/L  following bile diversion surgery. Burden of disease was mainly reported through health-related quality of life (HRQL), rates of surgery and survival. Rates of biliary diversion and liver transplant varied widely depending on study period, sample size and PFIC type, with many patients have multiple surgeries and progressing to liver transplant. This renders data unsuitable for comparison.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Using robust and transparent methods, this systematic review summarises our current knowledge of PFIC. The epidemiological overview is highly mixed and dependent on presentation and PFIC subtype. Only two studies reported HRQL and mortality results were variable across different subtypes. Lack of data and extensive heterogeneity severely limit understanding across this disease area, particularly variation around and within subtypes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-021-01884-4","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T07:09:23Z","timestamp":1622704163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Epidemiology and burden of progressive familial intrahepatic cholestasis: a systematic review"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9760-6628","authenticated-orcid":false,"given":"Tracey","family":"Jones-Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Crathorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"1884_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/HMER.S137209","volume":"10","author":"M Gunaydin","year":"2018","unstructured":"Gunaydin M, Cil ATB. Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment. Hepat Med. 2018;10:95.","journal-title":"Hepat Med"},{"issue":"1","key":"1884_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jhep.2010.01.034","volume":"53","author":"L Pawlikowska","year":"2010","unstructured":"Pawlikowska L, Strautnieks S, Jankowska I, Czubkowski P, Emerick K, Antoniou A, et al. Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol. 2010;53(1):170\u20138.","journal-title":"J Hepatol"},{"issue":"1","key":"1884_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jceh.2013.10.005","volume":"4","author":"A Srivastava","year":"2014","unstructured":"Srivastava A. Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol. 2014;4(1):25\u201336.","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"1884_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.5500\/wjt.v6.i2.278","volume":"6","author":"A Mehl","year":"2016","unstructured":"Mehl A, Bohorquez H, Serrano M-S, Galliano G, Reichman TW. Liver transplantation and the management of progressive familial intrahepatic cholestasis in children. World J Transplant. 2016;6(2):278.","journal-title":"World J Transplant"},{"issue":"1","key":"1884_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clinre.2018.07.010","volume":"43","author":"A Baker","year":"2019","unstructured":"Baker A, Kerkar N, Todorova L, Kamath BM, Houwen RH. Systematic review of progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol. 2019;43(1):20\u201336.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1884_CR6","unstructured":"The Joanna Briggs Institute. Checklist for prevalence studies [Available from: http:\/\/joannabriggs.org\/research\/critical-appraisal-tools.html."},{"issue":"4","key":"1884_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jpedsurg.2008.07.018","volume":"44","author":"AR Davis","year":"2009","unstructured":"Davis AR, Rosenthal P, Newman TB. Nontransplant surgical interventions in progressive familial intrahepatic cholestasis. J Pediatr Surg. 2009;44(4):821\u20137.","journal-title":"J Pediatr Surg"},{"issue":"2","key":"1884_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/MPG.0000000000002789","volume":"71","author":"HJ Verkade","year":"2020","unstructured":"Verkade HJ, Thompson RJ, Arnell H, Fischler B, Gillberg PG, Mattsson JP, et al. Systematic review and meta-analysis: partial external biliary diversion in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 2020;71(2):176\u201383.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"1884_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00383-020-04641-z","volume":"36","author":"HR Foroutan","year":"2020","unstructured":"Foroutan HR, Bahador A, Ghanim SM, Dehghani SM, Anbardar MH, Fattahi MR, et al. Effects of partial internal biliary diversion on long-term outcomes in patients with progressive familial intrahepatic cholestasis: experience in 44 patients. Pediatr Surg Int. 2020;36(5):603\u201310.","journal-title":"Pediatr Surg Int"},{"issue":"7","key":"1884_CR10","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jpedsurg.2019.09.018","volume":"55","author":"V Van Vaisberg","year":"2020","unstructured":"Van Vaisberg V, Tannuri ACA, Lima FR, Tannuri U. Ileal exclusion for pruritus treatment in children with progressive familial intrahepatic cholestasis and other cholestatic diseases. J Pediatr Surg. 2020;55(7):1385\u201391.","journal-title":"J Pediatr Surg"},{"issue":"1","key":"1884_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","volume":"73","author":"DBE van Wessel","year":"2020","unstructured":"van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Sokal E, Grammatikopoulos T, et al. Genotype correlates with the natural history of severe bile salt export pump deficiency. J Hepatol. 2020;73(1):84\u201393.","journal-title":"J Hepatol"},{"issue":"3","key":"1884_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/MPG.0000000000001385","volume":"64","author":"A Thebaut","year":"2017","unstructured":"Thebaut A, Habes D, Gottrand F, Rivet C, Cohen J, Debray D, et al. Sertraline as an additional treatment for cholestatic pruritus in children. J Pediatr Gastroenterol Nutr. 2017;64(3):431\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1884_CR13","unstructured":"Valamparampil J, Shanmugam N, Reddy MS, Rela M. Liver transplantation in progressive familial intrahepatic cholestasis: outcome analysis from a single centre. Transplantation. 2018;102(5 Supplement 1):141\u20132."},{"issue":"Supplement 1","key":"1884_CR14","first-page":"117A","volume":"68","author":"D Van Wessel","year":"2018","unstructured":"Van Wessel D, Thompson RJ, Grammatikopoulos T, Kadaristiana A, Jankowska I, Lipinski P, et al. The natural course of BSEP deficiency: Results from the global napped-consortium. Hepatol. 2018;68(Supplement 1):117A-A118.","journal-title":"Hepatol"},{"issue":"Supplement 1","key":"1884_CR15","first-page":"1051A","volume":"68","author":"D Van Wessel","year":"2018","unstructured":"Van Wessel D, Thompson RJ, Grammatikopoulos T, Kadaristiana A, Jankowska I, Lipinski P, et al. The natural course of fic1 deficiency: Results from the napped-consortium. Hepatol. 2018;68(Supplement 1):1051A-A1052.","journal-title":"Hepatol"},{"issue":"Supplement 2","key":"1884_CR16","first-page":"650","volume":"66","author":"D Van Wessel","year":"2018","unstructured":"Van Wessel D, Thompson R, Grammatikopoulos T, Kadaristiana A, Jankowska I, Lipinski P, et al. The natural course of FIC1 deficiency and BSEP deficiency: Initial results from the NAPPEDconsortium (NAtural course andprognosis of PFIC and effect of biliary diversion). J Pediatr Gastroenterol Nutr. 2018;66(Supplement 2):650\u20132.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Supplement 1","key":"1884_CR17","doi-asserted-by":"publisher","first-page":"S626","DOI":"10.1016\/S0168-8278(18)31509-5","volume":"68","author":"D Van Wessel","year":"2018","unstructured":"Van Wessel D, Thompson R, Grammatikopoulos T, Kadaristiana A, Jankowska I, Lipinski P, et al. The natural course of FIC1 deficiency and BSEP deficiency: Initial results from the NAPPED-consortium (Natural course and Prognosis of PFIC and Effect of biliary Diversion). J Hepatol. 2018;68(Supplement 1):S626\u20137.","journal-title":"J Hepatol"},{"issue":"Supplement 1","key":"1884_CR18","first-page":"688","volume":"68","author":"D Van Wessel","year":"2019","unstructured":"Van Wessel D, Thompson R, Grammatikopoulos T, Kadaristiana A, Jankowska I, Lipinski P, et al. Factors associated with the natural course of disease in patients with FIC1-deficiency: The NAPPED-consortium. J Pediatr Gastroenterol Nutr. 2019;68(Supplement 1):688\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1884_CR19","doi-asserted-by":"crossref","unstructured":"van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Sokal E, Grammatikopoulos T, et al. Genotype correlates with the natural history of severe bile salt export pump deficiency. Journal of Hepatology. 2020.","DOI":"10.1016\/j.jhep.2020.02.007"},{"issue":"Supplement 1","key":"1884_CR20","first-page":"918","volume":"68","author":"S Acar","year":"2019","unstructured":"Acar S, Demir B, Ayyildiz H, Polat KY, Kanmaz T, Akyildiz M, et al. Living donor liver transplantation for PFIC type 3. J Pediatr Gastroenterol Nutr. 2019;68(Supplement 1):918.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"1884_CR21","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.jpedsurg.2018.02.026","volume":"53","author":"CD Flores","year":"2018","unstructured":"Flores CD, Yu YR, Miloh TA, Goss J, Brandt ML. Surgical outcomes in alagille syndrome and PFIC: a single institution\u2019s 20-year experience. J Pediatr Surg. 2018;53(5):976\u20139.","journal-title":"J Pediatr Surg"},{"issue":"3","key":"1884_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jceh.2019.04.008","volume":"9","author":"JJ Valamparampil","year":"2019","unstructured":"Valamparampil JJ, Rinaldhy K, Reddy MS, Shanmugam N, Rela M. Outcomes of liver transplantation for pediatric recipients with progressive familial intrahepatic cholestasis. J Clin Exp Hepatol. 2019;9(3):422\u20133.","journal-title":"J Clin Exp Hepatol"},{"key":"1884_CR23","doi-asserted-by":"crossref","unstructured":"Van Vaisberg V, Tannuri ACA, Lima FR, Tannuri U. Ileal exclusion for pruritus treatment in children with progressive familial intrahepatic cholestasis and other cholestatic diseases. J Pediatr Surg. 2019.","DOI":"10.1016\/j.jpedsurg.2019.09.018"},{"key":"1884_CR24","doi-asserted-by":"crossref","unstructured":"Wang KS, Tiao G, Bass LM, Hertel PM, Mogul D, Kerkar N, et al. Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis. Hepatol. 2017;(no pagination).","DOI":"10.1002\/hep.29019"},{"issue":"1","key":"1884_CR25","first-page":"42","volume":"41","author":"HS Malik","year":"2017","unstructured":"Malik HS, Cheema HA, Hashmi MA, Waheed N, Anwar A, Anjum MN. Frequency of hepato-biliary disorders in children presenting at the children\u2019s hospital & the institute of child health, lahore, a tertiary care referral center. Pak Paed J. 2017;41(1):42\u20138.","journal-title":"Pak Paed J"},{"key":"1884_CR26","unstructured":"Meena BL, Khanna R, Sharma CB, Rawat D, Alam S. Ductal paucity in childhood: spectrum, profile and outcome. Hepatol Int. 2017;11(1 Supplement 1):S366."},{"issue":"4","key":"1884_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/MPG.0000000000000650","volume":"60","author":"AL Morris","year":"2015","unstructured":"Morris AL, Bukauskas K, Sada RE, Shneider BL. Byler disease: early natural history. J Pediatr Gastroenterol Nutr. 2015;60(4):460\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"1884_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/hep4.1149","volume":"2","author":"SB Schatz","year":"2018","unstructured":"Schatz SB, Jungst C, Keitel-Anselmo V, Kubitz R, Becker C, Gerner P, et al. Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset. Hepatol Commun. 2018;2(5):504\u201314.","journal-title":"Hepatol Commun"},{"issue":"Supplement 2","key":"1884_CR29","first-page":"793","volume":"66","author":"N Ruth","year":"2018","unstructured":"Ruth N, Sharif K, McGovern-Weijers A, Hartley J, Van Mourik I, Kelly D, et al. Long term outcome of children with PFIC-A single centre experience. J Pediatr Gastroenterol Nutr. 2018;66(Supplement 2):793\u20134.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1884_CR30","first-page":"S258","volume":"71","author":"H Alhebbi","year":"2020","unstructured":"Alhebbi H, Alhafaf F, Alqahtani A, Algubaisi S, Wali S. 391 Genetically confirmed familial cholestatic liver disorders in Saudi Arabia, a 22 years single center experience. J Pediatr Gastroenterol Nutr. 2020;71:S258.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1884_CR31","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/S0168-8278(20)30757-1","volume":"73","author":"RJ Thompson","year":"2020","unstructured":"Thompson RJ, Kelly D, Miethke A, Rajwal S, Soufi N, Jankowska I, et al. LBO08 Serum bile acid control in long-term maralixibat-treated patients is associated with native liver survival in children with progressive familial intrahepatic cholestasis due to bile salt export pump deficiency (S120). J Hepatol. 2020;73:S99\u2013122.","journal-title":"J Hepatol"},{"key":"1884_CR32","doi-asserted-by":"crossref","unstructured":"Bjornland K, Hukkinen M, Gatzinsky V, Arnell H, Pakarinen MP, Almaas R, et al. Partial Biliary Diversion May Promote Long-Term Relief of Pruritus and Native Liver Survival in Children with Cholestatic Liver Diseases. Eur J Pediatr Surg. 2020.","DOI":"10.1055\/s-0040-1714657"},{"key":"1884_CR33","doi-asserted-by":"crossref","unstructured":"Kamath BM, Chen Z, Romero R, Fredericks EM, Alonso EM, Arnon R, et al. Quality of life and its determinants in a multicenter cohort of children with Alagille syndrome. J Pediat. 2015;167(2):390\u20136. e3.","DOI":"10.1016\/j.jpeds.2015.04.077"},{"issue":"1","key":"1884_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1651-2227.2001.tb00261.x","volume":"90","author":"B Fischler","year":"2001","unstructured":"Fischler B, Papadogiannakis N, Nemeth A. Aetiological factors in neonatal cholestasis. Acta Paediatr. 2001;90(1):88\u201392.","journal-title":"Acta Paediatr"},{"key":"1884_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0168-8278(14)61408-2","volume":"60","author":"N Ruth","year":"2014","unstructured":"Ruth N, Gray Z, McKay K, Lloyd C, Hartley J, MacDonald F, et al. Identifying incidence of inherited metabolic disorders in patients with infantile liver disease. J Hepatol. 2014;60:505.","journal-title":"J Hepatol"},{"key":"1884_CR36","doi-asserted-by":"publisher","first-page":"S555","DOI":"10.1016\/S0168-8278(13)61380-X","volume":"58","author":"A Al Mehaidib","year":"2013","unstructured":"Al Mehaidib A, Al SA. 1381 progressive familial intrahepatic cholestasis in ARABS. J Hepatol. 2013;58:S555\u20136.","journal-title":"J Hepatol"},{"issue":"5","key":"1884_CR37","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/hep.23539","volume":"51","author":"A Davit-Spraul","year":"2010","unstructured":"Davit-Spraul A, Fabre M, Branchereau S, Baussan C, Gonzales E, Stieger B, et al. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatol. 2010;51(5):1645\u201355.","journal-title":"Hepatol"},{"issue":"10","key":"1884_CR38","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1097\/01.tp.0000282869.94152.4f","volume":"84","author":"C Englert","year":"2007","unstructured":"Englert C, Grabhorn E, Richter A, Rogiers X, Burdelski M, Ganschow R. Liver transplantation in children with progressive familial intrahepatic cholestasis. Transplantation. 2007;84(10):1361\u20133.","journal-title":"Transplantation"},{"key":"1884_CR39","doi-asserted-by":"crossref","unstructured":"Henriksen N, Drabl\u00f8s P, Aagenaes O. Cholestatic jaundice in infancy. The importance of familial and genetic factors in aetiology and prognosis. Arch Dis Childh. 1981;56(8):622\u20137.","DOI":"10.1136\/adc.56.8.622"},{"issue":"6","key":"1884_CR40","first-page":"610","volume":"15","author":"A Miyagawa-Hayashino","year":"2009","unstructured":"Miyagawa-Hayashino A, Egawa H, Yorifuji T, Hasegawa M, Haga H, Tsuruyama T, et al. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation. World J Transplant. 2009;15(6):610\u20138.","journal-title":"World J Transplant"},{"issue":"5","key":"1884_CR41","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1399-0012.2010.01368.x","volume":"25","author":"T Hori","year":"2011","unstructured":"Hori T, Egawa H, Takada Y, Ueda M, Oike F, Ogura Y, et al. Progressive familial intrahepatic cholestasis: a single-center experience of living-donor liver transplantation during two decades in Japan. Clin Transplant. 2011;25(5):776\u201385.","journal-title":"Clin Transplant"},{"issue":"3","key":"1884_CR42","first-page":"216","volume":"64","author":"W Lee","year":"2009","unstructured":"Lee W, Chai P, Looi L. Progressive familial intrahepatic cholestasis in Malaysian patients\u2014a report of five cases. Med J Malaysia. 2009;64(3):216\u20139.","journal-title":"Med J Malaysia"},{"issue":"sup2","key":"1884_CR43","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3402\/ijch.v63i0.17899","volume":"63","author":"I Nielsen","year":"2004","unstructured":"Nielsen I, Eiberg H. Cholestasis Familiaris Groelandica: an epidemiological, clinical and genetic study. Int J Circumpolar Health. 2004;63(sup2):192\u20134.","journal-title":"Int J Circumpolar Health"},{"issue":"4","key":"1884_CR44","first-page":"313","volume":"67","author":"C Wanty","year":"2004","unstructured":"Wanty C, Joomye R, Van NH, Paul K, Otte J-B, Reding R, et al. Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy. Acta Gastroenterol. 2004;67(4):313\u20139.","journal-title":"Acta Gastroenterol"},{"issue":"2","key":"1884_CR45","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/00005176-199402000-00003","volume":"18","author":"PF Whitington","year":"1994","unstructured":"Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ, Sharp HL. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 1994;18(2):134\u201341.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"1884_CR46","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/MPG.0000000000002118","volume":"67","author":"S Wassman","year":"2018","unstructured":"Wassman S, Pfister ED, Kuebler JF, Ure BM, Goldschmidt I, Dingemann J, et al. Quality of life in patients with progressive familial intrahepatic cholestasis: No difference between post-liver transplantation and post-partial external biliary diversion. J Pediatr Gastroenterol Nutr. 2018;67(5):643\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Supplement 1","key":"1884_CR47","first-page":"1047A","volume":"68","author":"K Yee","year":"2018","unstructured":"Yee K, Moshkovich O, Llewellyn S, Benjamin K, Desai NK. A web-based survey of itch severity after surgical treatment of progressive familial intrahepatic cholestasis in children and adolescents. Hepatol. 2018;68(Supplement 1):1047A.","journal-title":"Hepatol"},{"issue":"7","key":"1884_CR48","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jpedsurg.2007.10.055","volume":"43","author":"H Arnell","year":"2008","unstructured":"Arnell H, Bergdahl S, Papadogiannakis N, Nemeth A, Fischler B. Preoperative observations and short-term outcome after partial external biliary diversion in 13 patients with progressive familial intrahepatic cholestasis. J Pediatr Surg. 2008;43(7):1312\u201320.","journal-title":"J Pediatr Surg"},{"issue":"6","key":"1884_CR49","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1399-3046.2007.00722.x","volume":"11","author":"S Aydogdu","year":"2007","unstructured":"Aydogdu S, Cakir M, Arikan C, Tumgor G, Yuksekkaya HA, Yilmaz F, et al. Liver transplantation for progressive familial intrahepatic cholestasis: clinical and histopathological findings, outcome and impact on growth. Pediatr Transplant. 2007;11(6):634\u201340.","journal-title":"Pediatr Transplant"},{"issue":"12","key":"1884_CR50","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/0022-3468(95)90440-9","volume":"30","author":"JC Emond","year":"1995","unstructured":"Emond JC, Whitington PF. Selective surgical management of progressive familial intrahepatic cholestasis (Byler\u2019s disease). J Pediatr Surg. 1995;30(12):1635\u201341.","journal-title":"J Pediatr Surg"},{"issue":"3","key":"1884_CR51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/hep.510250303","volume":"25","author":"E Jacquemin","year":"1997","unstructured":"Jacquemin E, Hermans D, Myara A, Habes D, Debray D, Hadchouel M, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatol. 1997;25(3):519\u201323.","journal-title":"Hepatol"},{"issue":"1","key":"1884_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/MPG.0b013e3182a9097c","volume":"58","author":"I Jankowska","year":"2014","unstructured":"Jankowska I, Czubkowski P, Kalicinski P, Ismail H, Kowalski A, Ryzko J, et al. Ileal exclusion in children with progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 2014;58(1):92\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"1884_CR53","first-page":"313","volume":"67","author":"C Wanty","year":"2004","unstructured":"Wanty C, Joomye R, Van Hoorebeek N, Paul K, Otte JB, Reding R, et al. Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy. Acta Gastroenterol. 2004;67(4):313\u20139.","journal-title":"Acta Gastroenterol"},{"issue":"6","key":"1884_CR54","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1046\/j.1442-200x.1999.01143.x","volume":"41","author":"G Dinler","year":"1999","unstructured":"Dinler G, Kocak N, Ozen H, Yuce A, Gurakan F. Ursodeoxycholic acid treatment in children with Byler disease. Pediatr Int. 1999;41(6):662\u20135.","journal-title":"Pediatr Int"},{"key":"1884_CR55","doi-asserted-by":"crossref","unstructured":"van Wessel D, Thompson R, Grammatikopoulos T, Kadaristiana A, Jankowska I, Lipin?ski P, et al. Predicting long-term outcome after surgical biliary diversion in Bsep-deficiency patients: Results from the NAPPED consortium. J Hepatol. 2019;70(1):e121.","DOI":"10.1016\/S0618-8278(19)30213-0"},{"issue":"3","key":"1884_CR56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1034\/j.1399-3046.1999.00046.x","volume":"3","author":"H Ismail","year":"1999","unstructured":"Ismail H, Kalicinski P, Markiewicz M, Jankowska I, Pawlowska J, Kluge P, et al. Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion. Pediatr Transplant. 1999;3(3):219\u201324.","journal-title":"Pediatr Transplant"},{"issue":"3","key":"1884_CR57","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jpedsurg.2011.08.010","volume":"47","author":"N Schukfeh","year":"2012","unstructured":"Schukfeh N, Metzelder ML, Petersen C, Reismann M, Pfister ED, Ure BM, et al. Normalization of serum bile acids after partial external biliary diversion indicates an excellent long-term outcome in children with progressive familial intrahepatic cholestasis. J Pediatr Surg. 2012;47(3):501\u20135.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"1884_CR58","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/hep4.1168","volume":"2","author":"LN Bull","year":"2018","unstructured":"Bull LN, Pawlikowska L, Strautnieks S, Jankowska I, Czubkowski P, Dodge JL, et al. Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies. Hepatol Commun. 2018;2(5):515\u201328.","journal-title":"Hepatol Commun"},{"issue":"5","key":"1884_CR59","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jpedsurg.2010.02.010","volume":"45","author":"I Halaweish","year":"2010","unstructured":"Halaweish I, Chwals WJ. Long-term outcome after partial external biliary diversion for progressive familial intrahepatic cholestasis. J Pediatr Surg. 2010;45(5):934\u20137.","journal-title":"J Pediatr Surg"},{"issue":"Supplement 1","key":"1884_CR60","first-page":"702","volume":"68","author":"D Van Wessel","year":"2019","unstructured":"Van Wessel D, Thompson R, Grammatikopoulos T, Kadaristiana A, Jankowska I, Lipinski P, et al. Predicting long-term outcome after surgical biliary diversion in BSEP-deficiency patients: Results from the NAPPED consortium. J Pediatr Gastroenterol Nutr. 2019;68(Supplement 1):702\u20133.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"1884_CR61","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jceh.2016.05.003","volume":"6","author":"S Agarwal","year":"2016","unstructured":"Agarwal S, Lal BB, Rawat D, Rastogi A, Bharathy KGS, Alam S. Progressive familial intrahepatic cholestasis (PFIC) in Indian Children: clinical spectrum and outcome. J Clin Exp Hepatol. 2016;6(3):203\u20138.","journal-title":"J Clin Exp Hepatol"},{"issue":"Supplement 2","key":"1884_CR62","first-page":"723","volume":"66","author":"MS Cantez","year":"2018","unstructured":"Cantez MS, Onal Z, Guller D, Ekici F, Gulluoglu M, Soysal FG, et al. Diverse mutations and different clinical outcomes in children with progressive intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 2018;66(Supplement 2):723.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"13","key":"1884_CR63","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/hepr.13222","volume":"48","author":"L Chen","year":"2018","unstructured":"Chen L, Xiao H, Ren X-H, Li L. Long-term outcomes after cholecystocolostomy for progressive familial intrahepatic cholestasis. Hepatol Res. 2018;48(13):1163\u201371.","journal-title":"Hepatol Res"},{"issue":"3","key":"1884_CR64","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jpedsurg.2017.10.055","volume":"53","author":"B Erginel","year":"2018","unstructured":"Erginel B, Soysal FG, Durmaz O, Celik A, Salman T. Long-term outcomes of six patients after partial internal biliary diversion for progressive familial intrahepatic cholestasis. J Pediatr Surg. 2018;53(3):468\u201371.","journal-title":"J Pediatr Surg"},{"issue":"Suppl 2","key":"1884_CR65","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3402\/ijch.v63i0.17899","volume":"63","author":"IM Nielsen","year":"2004","unstructured":"Nielsen IM, Eiberg H. Cholestasis Familiaris Groenlandica: an epidemiological, clinical and genetic study. Int J Circumpolar Health. 2004;63(Suppl 2):192\u20134.","journal-title":"Int J Circumpolar Health"},{"issue":"1","key":"1884_CR66","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/hep.27834","volume":"62","author":"S Varma","year":"2015","unstructured":"Varma S, Revencu N, Stephenne X, Scheers I, Smets F, Beleza-Meireles A, et al. Retargeting of bile salt export pump and favorable outcome in children with progressive familial intrahepatic cholestasis type 2. Hepatol. 2015;62(1):198\u2013206.","journal-title":"Hepatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01884-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01884-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01884-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:29:55Z","timestamp":1778495395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-021-01884-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1884"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01884-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"assertion":[{"value":"21 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Funding was received from Albireo Pharma, Inc. for medical writing purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}